Genovis AB operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genovis AB with three other
companies in this sector in Sweden:
sales of 13.63 million Swedish Kronor [US$1.52 million]
Bioinvent International AB
(15.93 million Swedish Kronor [US$1.78 million]
of which 100%
was Drug Development), and
Active Biotech AB
(16.28 million Swedish Kronor [US$1.82 million]
of which 63%
was Rent and Services).
During the year ended December of 2015, sales at
Genovis AB were SEK 22.46 million (US$2.51 million).
increase of 134.9%
versus 2014, when the company's sales were SEK 9.56 million.